Welcome to the
Galenica network.
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market.
Annual report 2023: We create added value for the healthcare system
The 2023 financial year was characterised by opportunities, changes and challenges. At 4.4%, we once again achieved strong growth and further developed Galenica.
Perspectives in the Galenica network
Change in management at Pharmapool
Daniel Bühler became the new head of the Pharmapool Ltd. Business Unit on 1 June 2024. From 1 August 2024, he will also take over as Head of Project and Integration Management at Galexis.
Galenica on track with sales growth
The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024.
7th Annual General Meeting
The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern. The shareholders approved all the proposals put forward by the Board of Directors. They also approved the proposed dividend of CHF 2.20 per share.
Corporate
Information
Galenica (SIX Swiss Exchange)
73.55 CHF
Volume
0.00
06/28/2024 17:30
